2CG2.F · NanoSphere Health Sciences Inc

-

Please sign in to comment on 2CG2.F

1 Comment

Admin

4 years ago

NanoSphere Health Sciences Inc is currently in a long term downtrend where the price is trading 20.3% below its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.

NanoSphere Health Sciences Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has increased by 92.6% to $-65K since the same quarter in the previous year.

Finally, its free cash flow fell by 99.2% to $2K since the same quarter in the previous year.

Based on the above factors, NanoSphere Health Sciences Inc gets an overall score of 2/5.

Exchange	F
CurrencyCode	EUR
ISIN	None
Sector	Healthcare
Industry	Biotechnology

Market Cap	2M
Beta	0.21
PE Ratio	None
Target Price	None
Dividend Yield	None

ABOUT

NanoSphere Health Sciences Inc

Nanosphere Health Sciences Inc., a nano-biotechnology company, focuses on providing next generation delivery of biologically active compounds in the United States and Canada. It offers NanoSphere Deliver System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The company is headquartered in Vancouver, Canada.

2CG2.F · NanoSphere Health Sciences Inc

-

NanoSphere Health Sciences Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest NanoSphere Health Sciences Inc using a moving average strategy